Summary: Scientists have identified a method to induce a reversible, hibernation-like state that protects the brain after injury without relying on external cooling. By activating a specific population of hypothalamic neurons, researchers produced a controlled drop in body temperature that preserved neuronal health and improved motor recovery in mice.
Advanced imaging and histological analysis showed reduced neuroinflammation and greater neuronal survival in damaged brain regions. This discovery points to a potentially safer, more precise way to harness hypothermia’s neuroprotective effects for treating traumatic brain injury (TBI).
Key Facts:
- Internal Hypothermia: Stimulating a defined set of neurons triggers a reversible, hibernation-like state that lowers core body temperature without external cooling devices.
- Neuroprotection: Mice exposed to this neuron-induced hypothermia showed better motor coordination and stronger grip after brain injury.
- Reduced Inflammation: Imaging and tissue analyses showed decreased astrocytic and microglial activation at injury sites relative to controls.
Source: SfN
Background: Therapeutic hypothermia has long been known to slow cellular damage and inflammation after brain injury, but applying external cooling in patients can cause systemic complications and limit clinical use.
Recent work isolated a population of hypothalamic Q neurons whose activation induces a reversible, hypometabolic state—termed Q neuron-induced hypothermia (QIH)—that mimics aspects of hibernation without external cooling. Researchers asked whether QIH could deliver the neuroprotective benefits of hypothermia while avoiding the drawbacks of external cooling.
In a new Journal of Neuroscience paper led by Takeshi Sakurai at the University of Tsukuba, investigators evaluated QIH in male mice subjected to acute brain injuries. The study used dorsal striatal and medial prefrontal cortex injury models to assess functional recovery and inflammatory responses.
Mice treated with QIH showed significant improvements in motor performance and grip strength compared with untreated controls. Histology of the lesioned striatum demonstrated greater neuronal survival in the tissue surrounding the injury and marked reductions in astrocytic gliosis and microglial accumulation.
Using the prefrontal cortex injury model to probe mechanisms, the team found that QIH strongly suppressed markers of astrocyte and microglial activation—specifically lower GFAP and Iba1 expression. The treatment also reduced the numbers of CD16/32- and CD68-positive microglia and decreased inducible nitric oxide synthase (iNOS) expression, indicating a dampened oxidative and phagocytic inflammatory response.
Morphological analyses revealed a shift in microglial shapes toward ramified and rod-like forms, phenotypes typically associated with non-inflammatory or protective microglial states. Together, these changes point to early suppression of neuroinflammation, preservation of neuronal integrity, and enhanced functional recovery after brain injury.
Although these findings are preclinical, the authors emphasize that QIH represents a physiologically grounded strategy to achieve hypothermia’s benefits while potentially avoiding systemic complications linked to external cooling methods. The study highlights the therapeutic promise of modulating endogenous thermoregulatory circuits to protect the injured brain.
Looking ahead, Sakurai and colleagues note the need to refine treatment parameters and safety: “Optimizing the timing and duration of this treatment after injury, testing across additional injury models, and evaluating safety and efficacy in larger animals will be important next steps.”
Key Questions Answered:
A: Hypothermia therapy lowers core body temperature to slow cellular damage and inflammation after injury, helping preserve neurons and improve recovery.
A: Instead of externally cooling the body, this approach activates a natural, neuron-driven hypothermic state that lowers metabolism and temperature from within.
A: By relying on endogenous mechanisms, neuron-induced hypothermia could enable safer, more targeted neuroprotection without the systemic risks associated with external cooling.
About this neurology research news
Author: SfN Media
Source: SfN
Contact: SfN Media – SfN
Image: Image credited to Neuroscience News
Original Research: Closed access. “Q Neuron-Induced Hypothermia Promotes Functional Recovery and Suppresses Neuroinflammation After Brain Injury” by Takeshi Sakurai et al., Journal of Neuroscience.
Abstract
Q Neuron-Induced Hypothermia Promotes Functional Recovery and Suppresses Neuroinflammation After Brain Injury
Traumatic brain injury initiates secondary processes—such as neuroinflammation and glial activation—that drive progressive neuronal loss and impair functional recovery. While therapeutic hypothermia can offer neuroprotection, its clinical use is limited by systemic complications from external cooling.
Recent studies have identified hypothalamic Q neurons whose activation produces a reversible, hibernation-like hypometabolic state (QIH) without external cooling. To determine whether QIH can reduce brain injury, this study assessed QIH’s effects after acute injury in male mice.
Using a dorsal striatal stab injury model, QIH-treated mice exhibited significantly better motor performance and grip strength than controls. Histological assessment showed increased neuronal survival in the perilesional striatum and markedly reduced astrocytic gliosis and microglial accumulation at the injury site.
In a medial prefrontal cortex injury model, QIH suppressed astrocytic and microglial activation, demonstrated by lower GFAP and Iba1 levels. QIH also decreased CD16/32- and CD68-positive microglia and downregulated iNOS expression, indicating reduced oxidative and phagocytic inflammatory responses. Morphometric analysis revealed a shift toward ramified and rod-shaped microglia, phenotypes linked to neuroprotective functions.
These findings show that QIH mitigates early neuroinflammation, preserves neuronal structure, and supports functional recovery after brain injury. The results position QIH as a novel, physiologically based neuroprotective approach that may overcome the limitations of conventional hypothermia therapies.